Search Results
ACC 23: TAVR in Low-Risk Aortic Stenosis Patients: 3-Year Results From the Evolut Low Risk Trial
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
Overview of PARTNER 3 & Evolut Low Risk TAVR Trials
ACCess Points – EVOLUT LOW RISK | ACC.23/WCC
Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR
Medtronic Evolut Transcatheter Aortic Valve Replacement (TAVR) at TCT 2023
How PAIN Can Be Your TICKET to Spiritual Liberation! | Consciousness & Evolution
La SEC te lleva a ACC19 [IN] ∙ EVOLUT LOW RISK Trial
ACC Cardiology Hour From ACC.23 Together With WCC
3-year Outcomes EVOLUT Low Risk Trial
Breaking News: Medtronic TAVR Low-Risk Clinical Trial Results Released!
Episode 26 | The Latest Advances in TAVR: How to Significantly Reduce Conduction Disturbances
![La SEC te lleva a ACC19 [IN] ∙ EVOLUT LOW RISK Trial](https://img.youtube.com/vi/Sdgo1bZNA18/hqdefault.jpg)
